Abstract
The detection of glycans and glycoconjugates has gained increasing attention in biological fields. Traditional mass spectrometry (MS)-based methods for glycoconjugate analysis are challenged with poor intensity when dealing with complex biological samples. We developed a desalting paper spray mass spectrometry (DPS-MS) strategy to overcome the issue of signal suppression of carbohydrates in salted buffer. Glycans and glycoconjugates (i.e., glycopeptides, nucleotide sugars, etc.) in non-volatile buffer (e.g., Tris buffer) can be loaded on the paper substrate from which buffers can be removed by washing with ACN/H2O (90/10 v/v) solution. Glycans or glycoconjugates can then be eluted and spray ionized by adding ACN/H2O/formic acid (FA) (10/90/1 v/v/v) solvent and applying a high voltage (HV) to the paper substrate. This work also showed that DPS-MS is applicable for direct detection of intact glycopeptides and nucleotide sugars as well as determination of glycosylation profiling of antibody, such as NIST monoclonal antibody IgG (NISTmAb). NISTmAb was deglycosylated with PNGase F to release N-linked oligosaccharides. Twenty-six N-linked oligosaccharides were detected by DPS-MS within a 5-minute timeframe without the need for further enrichment or derivatization. This work demonstrates that DPS-MS allows fast and sensitive detection of glycans/oligosaccharides and glycosylated species in complex matrices and has great potential in bioanalysis.
Graphical Abstract
Introduction
Glycosylation refers to the process of the addition of carbohydrate or glycan chains to proteins,1 lipid molecules,2 RNA,3 or other biomolecules,4–5 which are referred to as glycoconjugates. This post-translational modification is critical for the function and characteristics of glycoconjugates, such as conformation, stability, pharmacokinetic and pharmacodynamic properties,6–7 and protease resistance.8 Many proteins are glycosylated and glycan chains are linked to the nitrogen atoms of asparagine residue by an N-glycosidic bond (N-linked glycans) or to the oxygen atoms of serine/threonine residues by an O-glycosidic bond (O-linked glycans). Biosynthesis of N-glycans is a complex process in eukaryotic cells including mammals,9 which typically involves the catalysis of glycosyltransferases (GTs) using nucleotide sugar donors (e.g., monosaccharide building blocks activated by nucleoside mono- or diphosphate).10 As an important class of glycoproteins, monoclonal antibodies (mAb) are key therapeutics for a range of diseases including cancer, infections and autoimmune disorders.11–14 The glycan composition impacts the stability and safety in the development of most antibody based biotherapeutics.15–17 In particular, oligosaccharides on Asn297 of the Fc region play an essential role in Fc effector functions that are key mechanisms of therapeutic action18–19, hence the influence of therapeutic efficacy drives an intense focus on glycoengineering of the attached glycoforms.20 Therefore, due to the impact of glycosylation on the structures and functions of proteins or other biomolecules, structural characterization of glycans and glycoconjugates is critical.
Electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser desorption-ionization mass spectrometry (MALDI-MS) are often used to characterize glycans.21–24 Accurate molecular mass, along with tandem mass analysis, provides unprecedented capability for glycan structure characterization and sugar sequence assignment.25–30 However, due to signal suppression by more readily ionized compounds (e.g., salts and other solutes like detergents, chaotropes that are often used in proteomics sample preparation step31–32), it is still challenging to detect and analyze glycans/oligosaccharides in complex biological mixtures.33 Therefore, efficient ionization and detection of carbohydrates require enrichment and desalting steps. Existing desalting methods include chromatography34–44 and capillary electrophoresis,45–49 which are time-consuming (time ranging from 50 mins up to 2 hrs) and have limitations such as low enrichment efficiency and nonspecific binding of oligosaccharides due to their high polarities. Additionally, derivatization is needed prior to MS analysis due to the low ionization efficiency of oligosaccharides, which also brings the limitation of laborious procedure and extensive experiment time. Thus, developing a fast and sensitive MS detection method for analysis of glycans/oligosaccharides in complex matrices is needed.
Direct sampling ionization by ambient ionization MS has attracted more attention in the past decade.50–52 Paper spray ionization (PSI) is one of the most popular ambient ionization techniques that has emerged in recent years.53–55 Paper spray involves paper substrates cut to triangular shapes with sharp points, onto which samples are loaded. Next, spray solvent and high-voltage (HV) are applied to the paper for simultaneous elution and ionization. Since its introduction in 2010 by Ouyang, Cooks, and co-workers,56 paper spray has been developed for various clinical,57–59 food safety,60 and forensic applications.61–63 However, only few studies have been reported on large carbohydrate molecules. However, analysis of glycans from complex matrices using PSI-MS is still lacking, probably because the conventional PSI solvent (MeOH or ACN/H2O 50/50 v/v) cannot elute target oligosaccharides from the paper due to their strong hydrophilic interaction with the fibrous paper.64–66 Li et al. developed a hydrophobic polystyrene-impregnated paper substrate for protein and peptide analysis by first coating polystyrene microspheres followed by baking at a high temperature.67 Riboni et al. designed a new setup named Solvent-Assisted Paper Spray Ionization (SAPSI) that integrates a power supply and fluidics system to prolong analysis time for protein, peptide and N-glycans.68 Recently, we developed a desalting paper spray ionization (DPS) method for the rapid analysis of oligosaccharides in complex matrices or from enzymatic reactions, which employs a triangular filter paper for both sample desalting and ionization (desalting refers to removal of excess amount of non-volatile buffers and inorganic salts).69 The rationale is that the paper substrate for spray ionization consists mainly of cellulose which could have strong interactions with oligosaccharides via hydrogen bonding and thus can serve as a stationary phase for desalting purpose.
In this study, we further extended the application of DPS-MS for detecting low amounts of various glycans with complex structures, as well as glycopeptides in the presence of non-volatile buffers. Our findings indicate that simple one-step desalination resulted in the elimination of signal suppression from non-volatile buffer without compromising the desirable qualities of paper spray, namely short analysis time, minimum sample pretreatment, accuracy, and simplicity. DPS-MS uses ACN/H2O (90/10 v/v) to wash away unbound salts and other chemicals in sample mixtures before elution of glycans/oligosaccharides with higher water content (ACN/H2O/FA, 10/90/1 v/v/v) for ionization. DPS-MS successfully detected various glycans/oligosaccharides, including sialylated and non-sialylated glycopeptides as well as nucleotide sugars in non-volatile buffers. We further extended the study to include N-glycan analysis from deglycosylated antibody (NISTmAb), which brings a new perspective for DPS-MS, as a valuable tool for clinical and pharmaceutical applications.
Experimental Section
Materials
Xyloglucan (XyG) heptasaccharide, 63, 64-α-D-Galactosyl-mannopentaose, 23-(4-O-Methyl-α-D-Glucuronosyl)-xylotetraose, 63-α-D-Glucosyl-maltotriosyl-maltotriose and 23,33-di-α-L-Arabinofuranosyl-xylotriose were obtained from Megazyme (Bray, Ireland). β-cyclodextrin, vancomycin hydrochloride and ammonium hydroxide were from Sigma-Aldrich (St. Louis, MO, United States). Sialylglycopeptide was from Tokyo Chemical Industry Co. (Tokyo, Japan). A UDP-glucuronate sample mixture in 2.5 mM Tris buffer (pH 7.4) with 50 μM MgCl2 and 50 μM MnCl2 was received from Sigma-Aldrich (St. Louis, MO, United States). Humanized IgG1κ monoclonal antibody (NISTmAb) was NIST reference material 8671 purchased from NIST. HPLC-grade acetonitrile, 1 M Tris-HCl buffer solution (pH 7.0), formic acid was from Fisher Scientific (Waltham, MA, United States). Deionized water was from EMD Millipore (Burlington, MA, United States). Whatman-grade 42 and 2.5 μm chromatography paper was from Whatman International Ltd. (Maidstone, England). Rapid PNGase F enzyme was purchased from New England Biolabs (Ipswich, MA, United States).
Instrument setup
Mass analysis was performed by using a high-resolution Q Exactive Orbitrap mass spectrometer (Thermo Scientific, San Jose, CA, USA) with ion source removed to accommodate PSI, DPS and nano-ESI setups. The capillary temperature was set at 250°C. Spray voltage was 3.0 kV at positive ion mode and 3.5 kV in negative ion mode. Tandem mass spectra were acquired using collision-induced dissociation (CID).
Experimental Procedures
DPS-MS Method
The DPS method was slightly modified based on a previously described method.69 The filter paper was cut into a triangular shape (15 × 10 mm, height × base) followed by sequential sonication-assisted cleaning in acetone, methanol, and methanol/water (50/50 v/v, 15 min each) and complete drying. Twenty μL of sample solution was dropped onto a paper triangle by loading 10 μL twice. The paper was placed over a Kimwipe to facilitate the absorption by capillarity as shown in Scheme 1a. The paper triangle was transferred onto a clean Kimwipe to perform desalting. Ten μL of ACN/H2O solution (90/10 v/v) was applied to the paper to remove salts and other chemicals. The washed paper triangle was then placed 8 mm in front of the MS inlet (see picture shown in Scheme 1b). A high-voltage cable alligator clip was used to hold the paper triangle and 10 μL of ACN/H2O/FA solution (10/90/1 v/v/v) was then applied to the paper triangle to elute the target compounds for ionization upon the application of high voltage.
Scheme 1.
a) Schematic showing the workflow and setup of our DPS-MS method. b) Picture showing the instrumental setup of DPS-MS.
PSI-MS Method
Filter paper was cut into a triangular shape (15 × 10 mm, height × base) followed by sequential sonication-assisted cleaning in acetone, methanol, and methanol/water (50/50 v/v, 15 min each) and complete drying. Sample solution (20 μL) was loaded onto the paper triangle. After total drying, the paper was held in front of the MS inlet with the same setup as for DPS (see previous section). 10 μL of ACN/H2O/FA solution (10/90/1 v/v/v) was then added to the paper triangle for elution of the target compounds and ionization upon the application of high voltage.
Nano-ESI-MS Method
A laser puller (model P1000, Sutter Instrument Inc, USA) was used to produce a conical-tip (o.d. ~15 μm) fused-silica capillary (100 μm i.d., 200 μm o.d., Polymicro Technologies, Phoenix, AZ). A syringe loaded with sample solution was attach to the capillary and held in front of the MS inlet with the application of high voltage (+3.0 kV) for ionization. The flow rate was 2 μL/min. The distance between the tip of the capillary and the MS was 8 mm.
Deglycosylation by PNGase F treatment
An optimized one-step protocol that utilizes Rapid PNGase F for deglycosylation of proteins was developed. Each reaction mixture contained 100 μg of NIST IgG antibody (NISTmAb) mixed with 6 μL of water, 4 μL of Rapid PNGase F Buffer (5X, the buffer composition information is proprietary) and 1 μL of Rapid PNGase F (0.8 mg/mL). The mixture was incubated overnight at 37°C in a water bath to release N-linked glycans (Scheme 2).
Scheme 2.
Deglycosylation of antibody by PNGase F. PNGase F reaction N-glycosylation sites is shown.
Results and Discussion
Optimization of DPS
First, we tested the optimal sample solution loading amount on the paper (10 × 5 mm, height × base) for the best signal intensity. In our previous DPS-MS workflow,69 10 μL was chosen as the sample loading volume. Optimization was achieved by increasing the sample loading volume on the paper triangle in series of 10 μL. Sample solution (10 μL) was loaded onto paper and allowed to be absorbed completely by the paper substrate (e.g., cellulose) before adding an additional 10 μL of sample, followed by a desalting step. The paper substrate was placed over a Kimwipe to facilitate capillarity as shown in Scheme 1a. For optimization, 50 μM β-cyclodextrin sample in 50 mM Tris-HCl (pH 7.0) buffer was used. The signal intensity of β-cyclodextrin, when loaded twice onto the paper triangle, was shown more than two times greater than when only loaded once (Figure S-1a, b, Supporting Information). Further additions of sample were also tested and our data indicated that the salt in the sample solution exceeded the desalting capacity of the paper triangle when a total of 30 μL of sample was used. The spectrum shows the reduced intensity of β-cyclodextrin peak due to the increased signal suppression resulting from the more abundant Tris clusters existing in the sample solution (Figure S-1c, Supporting Information). Thus, 20 μL of sample solution was selected as the optimal loading volume throughout this study.
Detection of oligosaccharides
Three standard oligosaccharides were tested in our previous work.69 In this study, we investigated a broader variety of oligosaccharides with different structure features such as long chains and branches. Oligosaccharides were dissolved in non-volatile Tris-HCl buffer to mimic a biological matrix. Solutions of XyG heptasaccharide (X3Glc4), 63, 64-α-D-Galactosyl-mannopentaose (GGM5), 23-(4-O-Methyl-α-D-Glucuronyl)-xylotetraose (XUXX), 63-α-D-Glucosyl-maltotriosyl-maltotriose (GMH), and 23,33-di-α-L-Arabinofuranosyl-xylotriose (A2,3XX), were prepared as 500 μM in 50 mM Tris-HCl buffer (pH 7.0). Scheme 3 shows the structure and chemical formula of these five oligosaccharides used in this experiment. DPS-MS was able to detect all of these oligosaccharides, namely, [Heptasaccharide +Na]+ at m/z 1085 (measured m/z 1085.33765, theoretical m/z 1085.33786, mass error: −0.19 ppm), [63, 64-α-D-Galactosyl-mannopentaose+Na]+ at m/z 1175 (measured m/z 1175.37109, theoretical m/z 1175.36955, mass error: 1.31 ppm), [23-(4-O-Methyl-α-D-Glucuronyl)-xylotetraose+Na]+ at m/z (measured m/z 759.21649, theoretical m/z 759.21656, mass error: −0.09 ppm), [63-α-D-Glucosyl-maltotriosyl-maltotriose+Na]+ at m/z (measured m/z 1175.36987, theoretical m/z 1175.36955, mass error: 0.27 ppm) and [23,33-di-α-L-Arabinofuranosyl-xylotriose+Na]+ at m/z (measured m/z 701.21124, theoretical m/z 701.21108, mass error: 0.23 ppm) (Figure 1). The protonated species of all five oligosaccharides were also detected but with intensity at 1 to 2 orders of magnitude less than the corresponding sodiated species (Figure 1).
Scheme 3.
Structure and chemical formula of five oligosaccharides detected by DPS-MS.
Figure 1.
DPS-MS spectra of a) 500 μM Heptasaccharide, b) 500 μM 63, 64-α-D-Galactosyl-mannopentaose, c) 500 μM 23-(4-O-Methyl-α-D-Glucuronyl)-xylotetraose, d) 500 μM 63-α-D-Glucosyl-maltotriosyl-maltotriose and e) 500 μM 23,33-di-α-L-Arabinofuranosyl-xylotriose in 50 mM Tris buffer.
The desalting power was further demonstrated by comparing DPS to conventional PSI and nano-ESI. Using 5 μM of 63, 64-α-D-Galactosyl-mannopentaose solution in 50 mM of Tris-HCl buffer (pH 7.0) as an example, the sodiated glycan ion at m/z 1175 was detected by DPS-MS with a signal intensity of 7.18E6 (Figure S-2a, Supporting Information). The signal intensity was reduced approximately 100-fold when PSI was used for detection (6.94E4, see Figure S-2b, Supporting Information), which was probably due to ion suppression by salts. By contrast, nano-ESI failed to detect galactosyl-mannopentaose from the sample (Figure S-2c, Supporting Information).
Detection of nucleotide sugars
Many chromatography-based methods such as ion exchange chromatography have been developed for the detection of nucleotide sugars.70–72 A major limitation of such method is the ion suppression effect from buffer with elevated salt contents in the electrospray ionization.71, 73–74 In our previous work,69 the detection of nucleotide sugars was not explored. In this study, we demonstrated DPS-MS analysis with uridine diphosphate-α-d-glucuronic acid (UDP-GlcA), a nucleotide sugar used as precursor for synthesis of many polysaccharides in animals and plants. A solution of 250 μM UDP-GlcA in 2.5 mM Tris-HCl buffer (pH 7.4) containing 50 μM MgCl2 and 50 μM MnCl2 was used to determine the capability of DPS to detect nucleotide sugars in non-volatile buffers. Ten μL of sample was loaded onto paper followed immediately by a desalting step before elution with 10 μL of ACN/H2O/NH4OH (90/10/1 v/v/v) as described in the Experimental Section. Ionization was in the negative ion mode at −3.5 kV. DPS was able to detect [UDP-GlcA-H]− ion at m/z 579 (measured m/z 579.02732, theoretical m/z 579.02591, mass error 2.45 ppm; Figure 2c) with signal intensity 6.44E6. By comparison, nano-ESI detected UDP-GlcA at signal intensity 4.99E5 (Figure 2a) and the conventional paper spray method did not detect UDP-GlcA signal under the same conditions (Figure 2b).
Figure 2.
MS spectra of 250 μM UDP-glucuronic acid in 2.5 mM Tris-HCl buffer (pH 7.4), 50 μM MgCl2 and 50 μM MnCl2 acquired by a) nano-ESI, b) conventional paper spray and c) desalting paper spray.
Detection of glycopeptides
Vancomycin (VCM) is a class of glycopeptide antibiotics used to treat infections caused by bacteria.75 Methods such as HPLC76–77 and capillary electrophoresis78 have been established and commonly used for the determination of VCM.79 To identify a highly sensitive, low-cost method with high separation efficiency and short analysis time for glycopeptide detection, we evaluated the DPS-MS method for detecting intact VCM glycopeptide. Vancomycin hydrochloride solution at 5 μM was prepared in 50 mM Tris-HCl buffer (pH 7.0) for detection by three methods: DPS-MS, PSI and nano-ESI. [Vancomycin+H]+ was detected at m/z 1448.43518 by DPS-MS (Figure 3a) with a mass error of 1.58 ppm (theoretical m/z 1448.43748). With conventional PSI (Figure 3b), VCM was detected at m/z 1448.43652 (mass error 0.66 ppm), but with about a 5-fold reduction in intensity. Also, we observed salt clusters in the spectra, which might have suppressed the signal of the glycopeptide. On the other hand, VCM was not detected by nano-ESI at the level of 5 μM (Figure 3c). The identity of the VCM peak was further confirmed through MS/MS spectra using collision-induced dissociation (CID). VCM at m/z 1448 initially produced a fragment ion at m/z 1305. The fragment ion then produced a series of characteristic product ions at m/z 1143, 1115 and 1087. Fragmentation of the polypeptide occurred with the loss of a hexose residue (C6H10O5, 162 Da) to produce a product ion at m/z 1143 and two consecutive CO losses to produce product ions at m/z 1115 and 1087 (Figure S3, Supporting Information). The observed pattern is consistent with the VCM fragmentation pathway.80
Figure 3.
MS spectra of 5 μM vancomycin in 50 mM Tris buffer acquired by a) desalting paper spray, b) conventional paper spray and c) nano-ESI compared with d) isotope simulation generated by Xcalibur.
Sialylation, a derivative of neuraminic acid, is one of the most common types of glycosylation observed in glycoproteins and is known to play a key role in protein stability, signal mediation, and cell-to-cell interactions, including adhesion, migration, and immune recognition.81–82 Additionally, sialic acid is known to be enriched in tumor cell surfaces to drive cancer malignancy.83 A number of MS-based methods are widely used for detection of protein sialyation. However, in the most common shotgun proteomics strategy, MS is operated in data-dependent mode (DDA), which favors the selection of high-abundance precursor ions over low-abundance species such as sialyl-glycopeptides (SGP).84 To overcome this limitation, various enrichment techniques have been developed.85–86 In this experiment, we sought to test the capability of DPS-MS for direct detection of intact SGP. A chemically synthesized SGP with eleven sugar constituents was prepared at a concentration of 50 μM in 50 mM Tris-HCl buffer (pH 7.0). The sample was loaded directly onto a paper triangle for DPS-MS detection. Abundant fragments of SGP with a sodium adduct carrying two charges was detected at m/z 1444.58655 (theoretical m/z 1444.58446, mass error: 1.45 ppm, Figure 4a). The same sample was also examined by conventional PSI and nano-ESI (Figure 4b, c), showing a decrease by 4-fold and 20-fold in signal intensity, respectively (DPS-MS: 9.42E6, PSI: 2.08E6, nano-ESI: 4.16E5). The second most abundant fragment was [SGP+H]+ detected at m/z 2866 by PSI and DPS, but was completely undetectable by nano-ESI. In other words, through the desalting step, the DPS-MS method was proven to be more tolerant for SGP in the presence of salted buffer. The potential utility of DPS-MS as a powerful peptide profiling tool was also demonstrated in Figure 4a. Multiple fragmentations were observed in the DPS spectra at m/z 2575, 2413, 2208, 2046, 1755 and 1593, corresponding to the natural dissociation pattern of SGP.87–88
Figure 4.
Panel a) showing the structure of sialyglycopeptide. MS spectra of 50 μM of sialylglycopeptide in 50 mM Tris buffer by b) desalting paper spray, c) conventional paper spray, and d) nano-ESI. Fragmentation ions of SGP are also labeled in b).
Detection of N-linked glycans released from glycoproteins
Glycosylation is a heterogeneous modification where a multitude of variables such as the type of host cell-line, cell culture conditions and genetic perturbations can influence glycan diversity during the development of monoclonal antibodies.89–90 A conserved N-linked glycan at Asn297 of the single-chain Fc (scFc) region of IgG1 is critical for the stability, conformation, aggregation, and effector function of therapeutic antibodies.91 Removing glycans prior to mass spectrometric analysis is a commonly used approach for glycan analysis. N-Glycosidase F (PNGase F), a recombinant glycosidase from Elizabethkingia miricola, is one of the most effective enzymes at cleaving N-linked oligosaccharides from glycoproteins. A scheme of NIST IgG1κ monoclonal antibody with the N-glycosylation sites labeled (NISTmAb) is shown above (Scheme 2). N-linked oligosaccharides were released from NISTmAb by Rapid PNGase F treatment. The digested sample was loaded directly onto a paper triangle for fast detection and analysis by DPS-MS within a 5 minutes timeframe. In Figure 5, five major ions were observed at m/z 1444.5, 1485.5, 1467.6, 1809.6 and 1971.7, corresponding to G1F-N, G0F, G1F, G2F and G2FGal oligosaccharides92 that are typical major glycans in IgGs. The most abundant glycans observed were G0F (measured m/z 1485.53188, theoretical m/z 1485.53365, mass error −1.19 ppm), G1F (measured m/z 1647.58462, theoretical m/z 1647.58648, mass error −1.13 ppm), and G2F (measured m/z 1809.63772, theoretical m/z 1809.63930, mass error −0.87 ppm). Remarkably, a total of 26 glycans were detected by DPS-MS. Table 1 summarizes the theoretical and the experimental monoisotopic mass assignments of these N-linked glycans. Among these N-glycans, 23 native glycoforms with sodium adducts in the positive ion mode carry one charge and 3 containing sialic acid with hydrogen adducts in the positive ion mode carry two charges. DPS-MS spectra of all 26 glycans are listed in Table S1, Supporting information. In contrast, no glycans were detected by either PSI-MS or nano-ESI method (Figure S4, Supporting information). Glycosylation of NISTmAb was previously characterized by three laboratories using HILIC with fluorescence detection of 2-AB-labeled N-glycans and collectively found 24 glycan peaks.93–94 In the NIST inter-laboratory study conducted in 2020, one hundred and three reports on glycan distributions of NISTmAb identified a total of 116 glycan compositions. The number of glycan compositions reported by each laboratory ranged from 4 to 48.95 By eliminating the necessity of time-consuming enrichment and derivatization approaches that involve extensive conditioning, washing and equilibrating steps in traditional glycoproteomics,96 DPS significantly reduces the analysis time and reagent cost for protein glycosylation analysis.
Figure 5.
DPS-MS spectra of N-glycans released from NIST IgG treated with Rapid PNGase F
Table 1.
Glycans observed from deglycosylated IgG mixtures as detected by DPS-MS
Composition | Symbol | Ion | Theoretical m/z | Measured m/z | Mass error (ppm) |
---|---|---|---|---|---|
HexNAc(1) | [M+Na]+ | 244.07916 | 244.07900 | −0.655525035 | |
HexNAc(2) | [M+Na]+ | 447.15853 | 447.15829 | −0.536722401 | |
HexNAc(1)Fuc(1) | [M+Na]+ | 390.13707 | 390.13683 | −0.615168407 | |
HexNAc(2)Fuc(1) | [M+Na]+ | 593.21644 | 593.21669 | 0.421431341 | |
HexNAc(2)Hex(3) | [M+Na]+ | 933.31700 | 933.31629 | −0.760727598 | |
HexNAc(2)Hex(3)Fuc(1) | [M+Na]+ | 1079.37491 | 1079.37398 | −0.8616098 | |
HexNAc(2)Hex(4) | [M+Na]+ | 1095.36982 | 1095.36899 | −0.757734954 | |
HexNAc(2)Hex(5) | M5 | [M+Na]+ | 1257.42265 | 1257.42253 | −0.095433306 |
HexNAc(2)Hex(6) | M6 | [M+Na]+ | 1419.47547 | 1419.47305 | −1.704855104 |
HexNAc(3)Hex(3) | G0-N | [M+Na]+ | 1136.39637 | 1136.39585 | −0.457586819 |
HexNAc(3)Hex(3)Fuc(1) | G0F-N | [M+Na]+ | 1282.45428 | 1282.45428 | 0 |
HexNAc(3)Hex(4) | [M+Na]+ | 1298.44920 | 1298.44998 | 0.600716609 | |
HexNAc(3)Hex(4)Fuc(1) | G1F-N | [M+Na]+ | 1444.50711 | 1444.50511 | −1.384555317 |
HexNAc(3)Hex(6) | [M+Na]+ | 1622.55484 | 1622.55640 | 0.961446702 | |
HexNAc(4)Hex(3) | G0 | [M+Na]+ | 1339.47575 | 1339.47436 | −1.037719421 |
HexNAc(4)Hex(3)Fuc(1) | G0F | [M+Na]+ | 1485.53365 | 1485.53188 | −1.191491017 |
HexNAc(4)Hex(4) | G1 | [M+Na]+ | 1501.52857 | 1501.52669 | −1.252057428 |
HexNAc(4)Hex(4)Fuc(1) | G1F | [M+Na]+ | 1647.58648 | 1647.58462 | −1.128924049 |
HexNAc(4)Hex(5) | G2 | [M+Na]+ | 1663.58139 | 1663.58245 | 0.637179525 |
HexNAc(4)Hex(5)Fuc(1) | G2F | [M+Na]+ | 1809.63930 | 1809.63772 | −0.87310217 |
HexNAc(4)Hex(6)Fuc(1) | G2FGal1 | [M+Na]+ | 1971.69212 | 1971.69410 | 1.004213579 |
HexNAc(5)Hex(4)Fuc(1) | G1FB | [M+Na]+ | 1850.66585 | 1850.66458 | −0.686239496 |
HexNAc(5)Hex(5)Fuc(1) | [M+Na]+ | 2012.71867 | 2012.71727 | −0.695576595 | |
HexNAc(4)Hex(4)Fuc(1)NeuAc(1) | G1S1F | [M+2H]2+ | 949.84833 | 949.84898 | 0.68431978 |
HexNAc(4)Hex(5)Fuc(1)NeuAc(1) | G2S1F | [M+2H]2+ | 1030.87474 | 1030.87275 | −1.93039942 |
HexNAc(4)Hex(5)Fuc(0)NeuAc(2) | G2S2 | [M+2H]2+ | 1103.39350 | 1103.39495 | 1.314127734 |
DPS sensitivity and reproducibility of peptide analysis
To evaluate the detection sensitivity of DPS-MS, samples containing a constant concentration of Tris-HCl buffer (50 mM) was spiked with 0.1, 0.5, 5, 50, and 100 μM of VCM which was selected as a test sample. As the Tris-HCl concentration to VCM ratio increased a thousand times from 5 × 102 to 5 × 105, the VCM signal at m/z 1448 was detected at intensities of 7.42E3, 3.00E4, 1.33E5, 1.75E6, and 3.17E6, respectively (Figure S5, Supporting information). Furthermore, a high correlation was observed when plotting the signal intensity of VCM against concentration (Figure S6, Supporting information). A linear trend with R2 = 0.9973 indicates that DPS-MS can be applicable for relative peptide quantitative analysis.
Reproducibility and signal stability were also examined in this study. With the aid of a three-axis XYZ platform (picture shown above in Scheme 1b), we were able to reproduce the results with high accuracy. To assess repeatability, we evaluated 5 replicates of VCM in 50 mM Tris-HCl buffer at the levels of 5 μM and 50 μM (Figure S7, Supporting information) to show the analysis of intensity repeatability. Five replicates were taken on the same day. Standard deviation and coefficient of variation of signal intensity for 5 μM and 50 μM VCM was 1.54E4, 9.0% and 2.13E5, 9.6% respectively. Five replicates were within 2 standard deviations (95%) (Figure S7a and b, Supporting information). The boxes represent the inter-quartile range, while the whiskers represent the full range of observed values (Figure S7c and d, Supporting information).
Conclusions
In summary, we have demonstrated the application of DPS-MS to detect different types of complex glycans and glycoconjugates (e.g., glycopeptides, nucleotide sugars). In contrast to other common methods for carbohydrate analysis, DPS-MS is simple to implement and can achieve high-throughput analysis that is free from more complex and time-consuming enrichment methods. Not only is our method accurate and sensitive, but it also overcomes common limitations of conventional paper spray related to salt-induced signal suppression. By using our approach, we successfully detected oligosaccharides, nucleotide sugars, glycopeptides, sialylated glycopeptides and mAb N-linked glycans in complex matrices. We believe rapid analysis of post-translational modifications such as N-linked glycosylation of antibodies demonstrated that DPS-MS technique can also be extended to other glycoproteins. Further improvements in instrumentation, robustness as well as potential quantitation of glycopeptides with incorporation of internal standard bring promising foreground to this technique in biological and clinical applications in glycoproteomics.
Supplementary Material
Acknowledgements
This work was supported by grants from NIH (1R15GM137311-01), NSF (CHE-1915878) and USDA (2019-6730-29670).
References
- 1.Schjoldager KT; Narimatsu Y; Joshi HJ; Clausen H, Global view of human protein glycosylation pathways and functions. Nature Reviews Molecular Cell Biology 2020, 21 (12), 729–749. [DOI] [PubMed] [Google Scholar]
- 2.Kopitz J, Lipid glycosylation: a primer for histochemists and cell biologists. Histochemistry and Cell Biology 2017, 147 (2), 175–198. [DOI] [PubMed] [Google Scholar]
- 3.Flynn RA; Pedram K; Malaker SA; Batista PJ; Smith BAH; Johnson AG; George BM; Majzoub K; Villalta PW; Carette JE; Bertozzi CR, Small RNAs are modified with N-glycans and displayed on the surface of living cells. Cell 2021, 184 (12), 3109–3124.e22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Shajahan A; Pepi LE; Rouhani DS; Heiss C; Azadi P, Glycosylation of SARS-CoV-2: structural and functional insights. Analytical and Bioanalytical Chemistry 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Tibullo D; Giallongo C; Romano A; Vicario N; Barbato A; Puglisi F; Parenti R; Amorini AM; Saab MW; Tavazzi B; Mangione R; Brundo MV; Lazzarino G; Palumbo GA; Li Volti G; Di Raimondo F; Lazzarino G, Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells. Biomolecules 2020, 10 (5), 696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Reusch D; Haberger M; Maier B; Maier M; Kloseck R; Zimmermann B; Hook M; Szabo Z; Tep S; Wegstein J; Alt N; Bulau P; Wuhrer M, Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods. MAbs 2015, 7 (1), 167–79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M, Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Glycobiology 2007, 17 (1), 104–18. [DOI] [PubMed] [Google Scholar]
- 8.Raju TS; Scallon BJ, Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain. Biochem Biophys Res Commun 2006, 341 (3), 797–803. [DOI] [PubMed] [Google Scholar]
- 9.Reily C; Stewart TJ; Renfrow MB; Novak J, Glycosylation in health and disease. Nature Reviews Nephrology 2019, 15 (6), 346–366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Seifert GJ, Nucleotide sugar interconversions and cell wall biosynthesis: how to bring the inside to the outside. Curr Opin Plant Biol 2004, 7 (3), 277–84. [DOI] [PubMed] [Google Scholar]
- 11.Cymer F; Beck H; Rohde A; Reusch D, Therapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential. Biologicals 2018, 52, 1–11. [DOI] [PubMed] [Google Scholar]
- 12.Costa AF; Campos D; Reis CA; Gomes C, Targeting Glycosylation: A New Road for Cancer Drug Discovery. Trends in Cancer 2020, 6 (9), 757–766. [DOI] [PubMed] [Google Scholar]
- 13.Dimitrov DS; Marks JD, Therapeutic antibodies: current state and future trends--is a paradigm change coming soon? Methods Mol Biol 2009, 525, 1–27, xiii. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Reichert JM; Valge-Archer VE, Development trends for monoclonal antibody cancer therapeutics. Nat Rev Drug Discov 2007, 6 (5), 349–56. [DOI] [PubMed] [Google Scholar]
- 15.Liu L, Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins. J Pharm Sci 2015, 104 (6), 1866–1884. [DOI] [PubMed] [Google Scholar]
- 16.Li T; DiLillo DJ; Bournazos S; Giddens JP; Ravetch JV; Wang LX, Modulating IgG effector function by Fc glycan engineering. Proc Natl Acad Sci U S A 2017, 114 (13), 3485–3490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gupta SK; Shukla P, Glycosylation control technologies for recombinant therapeutic proteins. Applied Microbiology and Biotechnology 2018, 102 (24), 10457–10468. [DOI] [PubMed] [Google Scholar]
- 18.Jefferis R, Glyco-Engineering of Human IgG-Fc to Modulate Biologic Activities. Curr Pharm Biotechnol 2016, 17 (15), 1333–1347. [DOI] [PubMed] [Google Scholar]
- 19.Boune S; Hu P; Epstein AL; Khawli LA, Principles of N-Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations. Antibodies 2020, 9 (2), 22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zheng K; Bantog C; Bayer R, The impact of glycosylation on monoclonal antibody conformation and stability. mAbs 2011, 3 (6), 568–576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Duffin KL; Welply JK; Huang E; Henion JD, Characterization of N-linked oligosaccharides by electrospray and tandem mass spectrometry. Anal. Chem 1992, 64, 1440–1448. [DOI] [PubMed] [Google Scholar]
- 22.Mock KK; Davey M; Cottrell JS, The analysis of underivatised oligosaccharides by Matrix-Assisted Laser Desorption Mass Spectrometry. Biochem. Biophys. Res. Commun 1991, 177, 644–651. [DOI] [PubMed] [Google Scholar]
- 23.Zhao X; Huang Y; Ma G; Liu Y; Guo C; He Q; Wang H; Liao J; Pan Y, Parallel On-Target Derivatization for Mass Calibration and Rapid Profiling of N-Glycans by MALDI-TOF MS. Anal.Chem 2020, 92, 991–998. [DOI] [PubMed] [Google Scholar]
- 24.Lattová E; Skřičková J; Zdráhal Z, Applicability of Phenylhydrazine Labeling for Structural Studies of Fucosylated N-Glycans. Anal. Chem 2019, 91, 7985–7990. [DOI] [PubMed] [Google Scholar]
- 25.Ji Y; Bachschmid MM; Costello CE; Lin C, S- to N-Palmitoyl Transfer During Proteomic Sample Preparation. J Am Soc Mass Spectrom 2016, 27, 677–685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Campbell MP; Abrahams JL; Rapp E; Struwe WB; Costello CE; Novotny M; Ranzinger R; York WS; Kolarich D; Rudd PM; Kettner C, The minimum information required for a glycomics experiment (MIRAGE) project: LC guidelines. Glycobiology 2019, 29, 349–354. [DOI] [PubMed] [Google Scholar]
- 27.Xu G; Davis JCC; Goonatilleke E; Smilowitz JT; German JB; Lebrilla CB, Absolute Quantitation of Human Milk Oligosaccharides Reveals Phenotypic Variations during Lactation. Nutr. J 2016, 147, 117–124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Fabijanczuk K; Gaspar K; Desai N; Lee J; Thomas DA; Beauchamp JL; Gao J, Resin and Magnetic Nanoparticle-Based Free Radical Probes for Glycan Capture, Isolation, and Structural Characterization. Anal. Chem 2019, 91, 15387–15396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Li S; Zhou Y; Xiao K; Li J; Tian Z, Selective fragmentation of the N-glycan moiety and protein backbone of ribonuclease B on an Orbitrap Fusion Lumos Tribrid mass spectrometer. Rapid Commun. Mass Spectrom 2018, 32, 2031–2039. [DOI] [PubMed] [Google Scholar]
- 30.Alley WR; Mann BF; Novotny MV, High-sensitivity Analytical Approaches for the Structural Characterization of Glycoproteins. Chem. Rev 2013, 113 (4), 2668–2732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Rabilloud T; Luche S; Santoni V; Chevallet M, Detergents and chaotropes for protein solubilization before two-dimensional electrophoresis. Methods Mol Biol 2007, 355, 111–9. [DOI] [PubMed] [Google Scholar]
- 32.Erde J; Loo RRO; Loo JA, Enhanced FASP (eFASP) to Increase Proteome Coverage and Sample Recovery for Quantitative Proteomic Experiments. Journal of Proteome Research 2014, 13 (4), 1885–1895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Iavarone AT; Udekwu OA; Williams ER, Buffer Loading for Counteracting Metal Salt-Induced Signal Suppression in Electrospray Ionization. Anal. Chem 2004, 76, 3944–3950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Maier M; Reusch D; Bruggink C; Bulau P; Wuhrer M; Mølhøj M, Applying mini-bore HPAEC-MS/MS for the characterization and quantification of Fc N-glycans from heterogeneously glycosylated IgGs. J. Chromatogr. B 2016, 1033–1034, 342–352. [DOI] [PubMed] [Google Scholar]
- 35.Zielinska DF; Gnad F; Wiśniewski JR; Mann M, Precision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints. Cell 2010, 141, 897–907. [DOI] [PubMed] [Google Scholar]
- 36.Vandenborre G; Van Damme EJM; Ghesquière B; Menschaert G; Hamshou M; Rao RN; Gevaert K; Smagghe G, Glycosylation Signatures in Drosophila: Fishing with Lectins. J. Proteome Res 2010, 9, 3235–3242. [DOI] [PubMed] [Google Scholar]
- 37.Cao C; Yu L; Yan J; Fu D; Yuan J; Liang X, Purification of natural neutral N-glycans by using two-dimensional hydrophilic interaction liquid chromatography × porous graphitized carbon chromatography for glycan-microarray assay. Talanta 2021, 221, 121382. [DOI] [PubMed] [Google Scholar]
- 38.Juvonen M; Kotiranta M; Jokela J; Tuomainen P; Tenkanen M, Identification and structural analysis of cereal arabinoxylan-derived oligosaccharides by negative ionization HILIC-MS/MS. Food. Chem 2019, 275, 176–185. [DOI] [PubMed] [Google Scholar]
- 39.Xia Y-G; Zhu R-J; Shen Y; Liang J; Kuang H-X, A high methyl ester pectin polysaccharide from the root bark of Aralia elata: Structural identification and biological activity. Int. J. Biol. Macromol 2020, 159, 1206–1217. [DOI] [PubMed] [Google Scholar]
- 40.Bereman MS; Williams TI; Muddiman DC, Development of a nanoLC LTQ Orbitrap Mass Spectrometric Method for Profiling Glycans Derived from Plasma from Healthy, Benign Tumor Control, and Epithelial Ovarian Cancer Patients. Anal. Chem 2009, 81, 1130–1136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu B-F; Cheng L; Liu X, Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer. J. Proteom 2018, 181, 160–169. [DOI] [PubMed] [Google Scholar]
- 42.Hua S; Saunders M; Dimapasoc LM; Jeong SH; Kim BJ; Kim S; So M; Lee K-S; Kim JH; Lam KS; Lebrilla CB; An HJ, Differentiation of Cancer Cell Origin and Molecular Subtype by Plasma Membrane N-Glycan Profiling. J. Proteome Res 2014, 13, 961–968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Xu G; Goonatilleke E; Wongkham S; Lebrilla CB, Deep Structural Analysis and Quantitation of O-Linked Glycans on Cell Membrane Reveal High Abundances and Distinct Glycomic Profiles Associated with Cell Type and Stages of Differentiation. Anal. Chem 2020, 92 (5), 3758–3768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G, Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis. J. Proteome Res 2019, 18 (6), 2559–2570. [DOI] [PubMed] [Google Scholar]
- 45.Balaguer E; Neusüss C, Glycoprotein Characterization Combining Intact Protein and Glycan Analysis by Capillary Electrophoresis-Electrospray Ionization-Mass Spectrometry. Analytical Chemistry 2006, 78 (15), 5384–5393. [DOI] [PubMed] [Google Scholar]
- 46.Huhn C; Ruhaak LR; Mannhardt J; Wuhrer M; Neusüß C; Deelder AM; Meyer H, Alignment of laser-induced fluorescence and mass spectrometric detection traces using electrophoretic mobility scaling in CE-LIF-MS of labeled N-glycans. Electrophoresis 2012, 33 (4), 563–566. [DOI] [PubMed] [Google Scholar]
- 47.Reusch D; Haberger M; Kailich T; Heidenreich A-K; Kampe M; Bulau P; Wuhrer M, High-throughput glycosylation analysis of therapeutic immunoglobulin G by capillary gel electrophoresis using a DNA analyzer. mAbs 2014, 6 (1), 185–196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Mahan AE; Tedesco J; Dionne K; Baruah K; Cheng HD; De Jager PL; Barouch DH; Suscovich T; Ackerman M; Crispin M; Alter G, A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis. Journal of Immunological Methods 2015, 417, 34–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Amon S; Zamfir AD; Rizzi A, Glycosylation analysis of glycoproteins and proteoglycans using capillary electrophoresis-mass spectrometry strategies. Electrophoresis 2008, 29 (12), 2485–2507. [DOI] [PubMed] [Google Scholar]
- 50.Takats ZW, J. M; Gologan B; Cooks RG, Mass Spectrometry Sampling Under Ambient Conditions with Desorption Electrospray Ionization. Science 2004, 306, 471–473. [DOI] [PubMed] [Google Scholar]
- 51.Cody RB; Laramee JA; Durst HD, Versatile New Ion Source for the Analysis of Materials in Open Air under Ambient Conditions. Anal. Chem 2005, 77, 2297–2302. [DOI] [PubMed] [Google Scholar]
- 52.Shin Y-S; Drolet B; Mayer R; Dolence K; Basile F, Desorption Electrospray Ionization-Mass Spectrometry of Proteins. Analytical Chemistry 2007, 79 (9), 3514–3518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Wang HL, J.; Cooks RG; Ouyang Z, Paper Spray for Direct Analysis of Complex Mixtures Using Mass Spectrometry. Angew. Chem., Int. Ed 2010, 49, 877–880. [DOI] [PubMed] [Google Scholar]
- 54.Cooks RG; Ouyang Z; Takats Z; Wiseman JM, Detection Technologies. Ambient mass spectrometry. Science 2006, 311 (5767), 1566–70. [DOI] [PubMed] [Google Scholar]
- 55.McBride EM; Mach PM; Dhummakupt ES; Dowling S; Carmany DO; Demond PS; Rizzo G; Manicke NE; Glaros T, Paper spray ionization: Applications and perspectives. TrAC Trends in Analytical Chemistry 2019, 118, 722–730. [Google Scholar]
- 56.Liu J; Wang H; Manicke NE; Lin J-M; Cooks RG; Ouyang Z, Development, Characterization, and Application of Paper Spray Ionization. Analytical Chemistry 2010, 82 (6), 2463–2471. [DOI] [PubMed] [Google Scholar]
- 57.Chiang S; Zhang W; Ouyang Z, Paper spray ionization mass spectrometry: recent advances and clinical applications. Expert review of proteomics 2018, 15 (10), 781–789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Chamberlain CA; Rubio VY; Garrett TJ, Strain-Level Differentiation of Bacteria by Paper Spray Ionization Mass Spectrometry. Analytical Chemistry 2019, 91 (8), 4964–4968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Shi R-Z; El Gierari ETM; Faix JD; Manicke NE, Rapid Measurement of Cyclosporine and Sirolimus in Whole Blood by Paper Spray–Tandem Mass Spectrometry. Clinical Chemistry 2016, 62 (1), 295–297. [DOI] [PubMed] [Google Scholar]
- 60.Guo T; Zhang Z; Yannell KE; Dong Y; Cooks RG, Paper spray ionization mass spectrometry for rapid quantification of illegal beverage dyes. Analytical Methods 2017, 9 (44), 6273–6279. [Google Scholar]
- 61.Teunissen SF; Fedick PW; Berendsen BJA; Nielen MWF; Eberlin MN; Graham Cooks R; van Asten AC, Novel Selectivity-Based Forensic Toxicological Validation of a Paper Spray Mass Spectrometry Method for the Quantitative Determination of Eight Amphetamines in Whole Blood. J Am Soc Mass Spectrom 2017, 28 (12), 2665–2676. [DOI] [PubMed] [Google Scholar]
- 62.Domingos E; de Carvalho TC; Pereira I; Vasconcelos GA; Thompson CJ; Augusti R; Rodrigues RRT; Tose LV; Santos H; Araujo JR; Vaz BG; Romão W, Paper spray ionization mass spectrometry applied to forensic chemistry – drugs of abuse, inks and questioned documents. Analytical Methods 2017, 9 (30), 4400–4409. [Google Scholar]
- 63.McKenna J; Jett R; Shanks K; Manicke NE, Toxicological Drug Screening using Paper Spray High-Resolution Tandem Mass Spectrometry (HR-MS/MS). Journal of Analytical Toxicology 2018, 42 (5), 300–310. [DOI] [PubMed] [Google Scholar]
- 64.Narayanan R; Song X; Chen H; Zare RN, Teflon Spray Ionization Mass Spectrometry. J Am Soc Mass Spectrom 2020, 31 (2), 234–239. [DOI] [PubMed] [Google Scholar]
- 65.Zhang Y; Ju Y; Huang C; Wysocki VH, Paper spray ionization of noncovalent protein complexes. Anal Chem 2014, 86 (3), 1342–6. [DOI] [PubMed] [Google Scholar]
- 66.Song X; Chen H; Zare RN, Conductive Polymer Spray Ionization Mass Spectrometry for Biofluid Analysis. Analytical Chemistry 2018, 90 (21), 12878–12885. [DOI] [PubMed] [Google Scholar]
- 67.Li J; Zheng Y; Mi W; Muyizere T; Zhang Z, Polystyrene-impregnated paper substrates for direct mass spectrometric analysis of proteins and peptides in complex matrices. Analytical Methods 2018, 10 (24), 2803–2811. [Google Scholar]
- 68.Riboni N; Quaranta A; Motwani HV; Osterlund N; Graslund A; Bianchi F; Ilag LL, Solvent-Assisted Paper Spray Ionization Mass Spectrometry (SAPSI-MS) for the Analysis of Biomolecules and Biofluids. Sci Rep 2019, 9 (1), 10296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Wang Q; Bhattarai M; Zhao P; Alnsour T; Held M; Faik A; Chen H, Fast and Sensitive Detection of Oligosaccharides Using Desalting Paper Spray Mass Spectrometry (DPS-MS). J Am Soc Mass Spectrom 2020, 31 (10), 2226–2235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Cohen S; Jordheim LP; Megherbi M; Dumontet C; Guitton J, Liquid chromatographic methods for the determination of endogenous nucleotides and nucleotide analogs used in cancer therapy: a review. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878 (22), 1912–28. [DOI] [PubMed] [Google Scholar]
- 71.Qin X; Wang X, Quantification of nucleotides and their sugar conjugates in biological samples: Purposes, instruments and applications. Journal of Pharmaceutical and Biomedical Analysis 2018, 158, 280–287. [DOI] [PubMed] [Google Scholar]
- 72.Sha S; Handelman G; Agarabi C; Yoon S, A high-resolution measurement of nucleotide sugars by using ion-pair reverse chromatography and tandem columns. Analytical and Bioanalytical Chemistry 2020, 412 (15), 3683–3693. [DOI] [PubMed] [Google Scholar]
- 73.Pabst M; Grass J; Fischl R; Léonard R; Jin C; Hinterkörner G; Borth N; Altmann F, Nucleotide and Nucleotide Sugar Analysis by Liquid Chromatography-Electrospray Ionization-Mass Spectrometry on Surface-Conditioned Porous Graphitic Carbon. Analytical Chemistry 2010, 82 (23), 9782–9788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Ito J; Herter T; Baidoo EEK; Lao J; Vega-Sánchez ME; Michelle Smith-Moritz A; Adams PD; Keasling JD; Usadel B; Petzold CJ; Heazlewood JL, Analysis of plant nucleotide sugars by hydrophilic interaction liquid chromatography and tandem mass spectrometry. Analytical Biochemistry 2014, 448, 14–22. [DOI] [PubMed] [Google Scholar]
- 75.Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue Y-K, Fidaxomicin versus Vancomycin for Clostridium difficile Infection. New England Journal of Medicine 2011, 364 (5), 422–431. [DOI] [PubMed] [Google Scholar]
- 76.Usman M; Hempel G, Development and validation of an HPLC method for the determination of vancomycin in human plasma and its comparison with an immunoassay (PETINIA). Springerplus 2016, 5, 124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Sheng Y; Zhou B, High-throughput determination of vancomycin in human plasma by a cost-effective system of two-dimensional liquid chromatography. J Chromatogr A 2017, 1499, 48–56. [DOI] [PubMed] [Google Scholar]
- 78.Wang J; Cao Y; Wu S; Wang S; Zhao X; Zhou T; Lou Y; Fan G, Determination of Vancomycin in Human Serum by Cyclodextrin-Micellar Electrokinetic Capillary Chromatography (CD-MEKC) and Application for PDAP Patients. Molecules 2017, 22 (4). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Liu M; Yang ZH; Li GH, A Novel Method for the Determination of Vancomycin in Serum by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Application in Patients with Diabetic Foot Infections. Molecules 2018, 23 (11). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Cao M; Feng Y; Zhang Y; Kang W; Lian K; Ai L, Studies on the metabolism and degradation of vancomycin in simulated in vitro and aquatic environment by UHPLC-Triple-TOF-MS/MS. Sci Rep 2018, 8 (1), 15471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Schauer R, Sialic acids: chemistry, metabolism, and function Springer Science & Business Media: 2012; Vol. 10. [Google Scholar]
- 82.Kohnz RA; Roberts LS; DeTomaso D; Bideyan L; Yan P; Bandyopadhyay S; Goga A; Yosef N; Nomura DK, Protein Sialylation Regulates a Gene Expression Signature that Promotes Breast Cancer Cell Pathogenicity. ACS Chem Biol 2016, 11 (8), 2131–2139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Bull C; Stoel MA; den Brok MH; Adema GJ, Sialic acids sweeten a tumor’s life. Cancer Res 2014, 74 (12), 3199–204. [DOI] [PubMed] [Google Scholar]
- 84.Stavenhagen K; Hinneburg H; Thaysen-Andersen M; Hartmann L; Varon Silva D; Fuchser J; Kaspar S; Rapp E; Seeberger PH; Kolarich D, Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides. J Mass Spectrom 2013, 48 (6), 627–39. [DOI] [PubMed] [Google Scholar]
- 85.Larsen MR; Jensen SS; Jakobsen LA; Heegaard NHH, Exploring the Sialiome Using Titanium Dioxide Chromatography and Mass Spectrometry *. Molecular & Cellular Proteomics 2007, 6 (10), 1778–1787. [DOI] [PubMed] [Google Scholar]
- 86.Liu Y; Liu Y; Zhang D; Zhang R; Li Z, Kapok Fiber: A Natural Biomaterial for Highly Specific and Efficient Enrichment of Sialoglycopeptides. Analytical Chemistry 2016, 88 (2), 1067–1072. [DOI] [PubMed] [Google Scholar]
- 87.Liu L; Prudden AR; Bosman GP; Boons G-J, Improved isolation and characterization procedure of sialylglycopeptide from egg yolk powder. Carbohydr Res 2017, 452, 122–128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Alagesan K; Kolarich D, Improved strategy for large scale isolation of sialylglycopeptide (SGP) from egg yolk powder. MethodsX 2019, 6, 773–778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Jefferis R, Glycosylation of Recombinant Antibody Therapeutics. Biotechnology Progress 2005, 21 (1), 11–16. [DOI] [PubMed] [Google Scholar]
- 90.Jefferis R, Glycosylation as a strategy to improve antibody-based therapeutics. Nature Reviews Drug Discovery 2009, 8 (3), 226–234. [DOI] [PubMed] [Google Scholar]
- 91.Jefferis R, Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 2009, 8 (3), 226–34. [DOI] [PubMed] [Google Scholar]
- 92.Neelamegham S; Aoki-Kinoshita K; Bolton E; Frank M; Lisacek F; Lütteke T; O’Boyle N; Packer NH; Stanley P; Toukach P; Varki A; Woods RJ; Group TSD, Updates to the Symbol Nomenclature for Glycans guidelines. Glycobiology 2019, 29 (9), 620–624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Halim A; Westerlind U; Pett C; Schorlemer M; Rüetschi U; Brinkmalm G; Sihlbom C; Lengqvist J; Larson G; Nilsson J, Assignment of Saccharide Identities through Analysis of Oxonium Ion Fragmentation Profiles in LC–MS/MS of Glycopeptides. Journal of Proteome Research 2014, 13 (12), 6024–6032. [DOI] [PubMed] [Google Scholar]
- 94.Prien JM; Stöckmann H; Albrecht S; Martin SM; Varatta M; Furtado M; Hosselet S; Wang M; Formolo T; Rudd PM; Schiel JE, Orthogonal Technologies for NISTmAb N-Glycan Structure Elucidation and Quantitation. In State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study, American Chemical Society: 2015; Vol. 1201, pp 185–235. [Google Scholar]
- 95.De Leoz MLA; Duewer DL; Fung A; Liu L; Yau HK; Potter O; Staples GO; Furuki K; Frenkel R; Hu Y; Sosic Z; Zhang P; Altmann F; Grunwald-Grube C; Shao C; Zaia J; Evers W; Pengelley S; Suckau D; Wiechmann A; Resemann A; Jabs W; Beck A; Froehlich JW; Huang C; Li Y; Liu Y; Sun S; Wang Y; Seo Y; An HJ; Reichardt N-C; Ruiz JE; Archer-Hartmann S; Azadi P; Bell L; Lakos Z; An Y; Cipollo JF; Pucic-Bakovic M; Štambuk J; Lauc G; Li X; Wang PG; Bock A; Hennig R; Rapp E; Creskey M; Cyr TD; Nakano M; Sugiyama T; Leung P-KA; Link-Lenczowski P; Jaworek J; Yang S; Zhang H; Kelly T; Klapoetke S; Cao R; Kim JY; Lee HK; Lee JY; Yoo JS; Kim S-R; Suh S-K; de Haan N; Falck D; Lageveen-Kammeijer GSM; Wuhrer M; Emery RJ; Kozak RP; Liew LP; Royle L; Urbanowicz PA; Packer NH; Song X; Everest-Dass A; Lattová E; Cajic S; Alagesan K; Kolarich D; Kasali T; Lindo V; Chen Y; Goswami K; Gau B; Amunugama R; Jones R; Stroop CJM; Kato K; Yagi H; Kondo S; Yuen CT; Harazono A; Shi X; Magnelli PE; Kasper BT; Mahal L; Harvey DJ; O’Flaherty R; Rudd PM; Saldova R; Hecht ES; Muddiman DC; Kang J; Bhoskar P; Menard D; Saati A; Merle C; Mast S; Tep S; Truong J; Nishikaze T; Sekiya S; Shafer A; Funaoka S; Toyoda M; de Vreugd P; Caron C; Pradhan P; Tan NC; Mechref Y; Patil S; Rohrer JS; Chakrabarti R; Dadke D; Lahori M; Zou C; Cairo C; Reiz B; Whittal RM; Lebrilla CB; Wu L; Guttman A; Szigeti M; Kremkow BG; Lee KH; Sihlbom C; Adamczyk B; Jin C; Karlsson NG; Örnros J; Larson G; Nilsson J; Meyer B; Wiegandt A; Komatsu E; Perreault H; Bodnar ED; Said N; Francois Y-N; Leize-Wagner E; Maier S; Zeck A; Heck AJR; Yang Y; Haselberg R; Yu YQ; Alley W; Leone JW; Yuan H; Stein SE, NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods *. Molecular & Cellular Proteomics 2020, 19 (1), 11–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Banazadeh A; Veillon L; Wooding KM; Zabet-Moghaddam M; Mechref Y, Recent advances in mass spectrometric analysis of glycoproteins. Electrophoresis 2017, 38 (1), 162–189. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.